Purpose TRIM29 overexpression has been reported in several human malignancies and showed correlation with cancer cell malignancy. The aim of the current study is to examine its clinical significance and biological roles in human bladder cancer tissues and cell lines. Materials and Methods A total of 102 cases of bladder cancer tissues were examined for TRIM29 expression by immunohistochemistry. siRNA and plasmid transfection were performed in 5637 and BIU- 87 cell lines. Cell Counting Kit-8, flow cytometry, western blot, and real-time polymerase chain reaction were performed to examine its biological roles and mechanism in bladder cancer cells.
Results We found that TRIM29 overexpression showed correlation with invading depth (p=0.0087). Knockdown of TRIM29 expression in bladder cancer cell line 5637 inhibited cell growth rate and cell cycle transition while its overexpression in BIU-87 cells accelerated cell proliferation and cell cycle progression. TRIM29 overexpression also inhibited cell apoptosis induced by cisplatin. In addition, we demonstrated that TRIM29 depletion decreased while its overexpression led to upregulated expression of cyclin D1, cyclin E, and Bcl-2. We also showed that TRIM29 knockdown inhibited protein kinase C (PKC) and nuclear factor κB (NF-κB) signaling while its overexpression stimulated the PKC and NF-κB pathways. BAY 11-7082 (NF-κB inhibitor) partly attenuated the effect of TRIM29 on expression of cyclin and Bcl-2. Treatment with PKC inhibitor staurosporine resulted in ameliorated TRIM29 induced activation of NF-κB. Conclusion The current study demonstrated that TRIM29 upregulates cyclin and Bcl family proteins level to facilitate malignant cell growth and inhibit drug-induced apoptosis in bladder cancer, possibly through PKC–NF-κB signaling pathways.
Citations
Citations to this article as recorded by
TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond Qitong Wu, Deeptashree Nandi, Dipali Sharma Cancer and Metastasis Reviews.2025;[Epub] CrossRef
Role of TRIM29 in disease: What is and is not known Kunying Lv, Qilong Li, Ning Jiang, Qijun Chen International Immunopharmacology.2025; 147: 113983. CrossRef
Lactate dehydrogenase A promotes nasopharyngeal carcinoma progression through the TAK1/NF-κB Axis Yingzi Li, Lanfang Chen, Qiaochong Zheng, Guanxin Liu, Mengjiao Wang, Shupei Wei, Tao Chen Molecular Biology Reports.2024;[Epub] CrossRef
Silencing TRIM29 Sensitizes Non-small Cell Lung Cancer Cells to
Anlotinib by Promoting Apoptosis via Binding RAD50 Min Wu, Meng-Meng Jin, Xiao-Hui Cao, Lei Zhao, Yong-Huai Li Current Cancer Drug Targets.2024; 24(4): 445. CrossRef
20-hydroxyecdysone suppresses bladder cancer progression via inhibiting USP21: A mechanism associated with deubiquitination and degradation of p65 Qiang Ma, Fei Wu, Xiaohui Liu, Cuifang Zhao, Yang Sun, Yuanyuan Li, Wei Zhang, Hongge Ju, Yukun Wang Translational Oncology.2024; 45: 101958. CrossRef
The Role and Mechanism of TRIM Proteins in Gastric Cancer Wangxi Wu, Jinyu Yang, Tian Yu, Zhuoling Zou, Xuan Huang Cells.2024; 13(24): 2107. CrossRef
Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape Junjie Gu, Jingyi Chen, Shuaixi Xiang, Xikun Zhou, Jing Li Journal of Advanced Research.2023; 54: 147. CrossRef
TRIM29 promotes podocyte pyroptosis in diabetic nephropathy through the NF‐kB/NLRP3 inflammasome pathway Xiaohong Xu, Zihan Qin, Ce Zhang, Xia Mi, Chi Zhang, Feihong Zhou, Junsheng Wang, Liexiang Zhang, Fei Hua Cell Biology International.2023; 47(6): 1126. CrossRef
Potential implications of protein kinase Cα in pathophysiological conditions and therapeutic interventions Rishi Kant Singh, Sanjay Kumar, Sandeep Kumar, Alok Shukla, Naveen Kumar, Anand Kumar Patel, Lokesh Kumar Yadav, Kaushalendra, Meera Antiwal, Arbind Acharya Life Sciences.2023; 330: 121999. CrossRef
TRIM29 promotes the progression of colorectal cancer by suppressing EZH2 degradation Yuanjian Chen, Jun Ma, Mingming Zhang Experimental Biology and Medicine.2023; 248(18): 1527. CrossRef
TRIM14 and TRIM29 as potential tumor markers for breast cancer diagnosis Mohammadreza Roshanazadeh, mojtaba rashidi, Arash sanaei, Hossein azizi dariuni, amirnader emami razavi, Maryam Adelipour Journal of Breast Disease.2023; 16(4): 4. CrossRef
TRIM29 regulates the SETBP1/SET/PP2A axis via transcription factor VEZF1 to promote progression of ovarian cancer Huai-Yu Qiao, Qi Zhang, Jia-Mei Wang, Jing-Yi Jiang, Ling-Yue Huyan, Jing Yan, Chao Li, Hua-Qin Wang Cancer Letters.2022; 529: 85. CrossRef
NCAPG promotes tumorigenesis of bladder cancer through NF-κB signaling pathway Feng Tang, Hua Yu, Xia Wang, Jiageng Shi, Zhizhuang Chen, Hao Wang, Ziyu Wan, Qiqi Fu, Xuan Hu, Yisha Zuhaer, Tao Liu, Zhonghua Yang, Jianping Peng Biochemical and Biophysical Research Communications.2022; 622: 101. CrossRef
Tripartite Motif Containing 26 is a Positive Predictor for
Endometrial Carcinoma Patients and Regulates Cell Survival in Endometrial
Carcinoma Tanmin Lu, Yu Wu Hormone and Metabolic Research.2022; 54(12): 859. CrossRef
TRIM3 and TRIM16 as potential tumor suppressors in breast cancer patients Mohammad Reza Roshanazadeh, Maryam Adelipour, Arash Sanaei, Hadi Chenane, Mojtaba Rashidi BMC Research Notes.2022;[Epub] CrossRef
Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer Takahito Kawano, Junichi Inokuchi, Masatoshi Eto, Masaharu Murata, Jeong-Hun Kang Cancers.2022; 14(21): 5425. CrossRef
Transcriptional dysregulation of TRIM29 promotes colorectal cancer carcinogenesis via pyruvate kinase-mediated glucose metabolism Jing Han, Zitong Zhao, Nan Zhang, Yang Yang, Liying Ma, Li Feng, Xue Zhang, Jing Zuo, Zhisong Fan, Yudong Wang, Yongmei Song, Guiying Wang Aging.2021; 13(4): 5034. CrossRef
E3 ubiquitin ligase TRIM29 promotes pancreatic cancer growth and progression via stabilizing Yes-associated protein 1 Xueqiang Deng, Xiaowei Fu, Hong Teng, Lu Fang, Bo Liang, Rengui Zeng, Lian Chen, Yeqing Zou Journal of Translational Medicine.2021;[Epub] CrossRef
Potential Immune Biomarker Candidates and Immune Subtypes of Lung Adenocarcinoma for Developing mRNA Vaccines Yang Wang, Huaicheng Tan, Ting Yu, Xiaoxuan Chen, Fangqi Jing, Huashan Shi Frontiers in Immunology.2021;[Epub] CrossRef
TRIM29 in Cutaneous Squamous Cell Carcinoma Che-Yuan Hsu, Teruki Yanagi, Hideyuki Ujiie Frontiers in Medicine.2021;[Epub] CrossRef
Molecular therapy with derivatives of amino benzoic acid inhibits tumor growth and metastasis in murine models of bladder cancer through inhibition of TNFα/NFΚB and iNOS/NO pathways Julie Girouard, Denise Belgorosky, Jovane Hamelin-Morrissette, Valerie Boulanger, Ernesto D'Orio, Djamel Ramla, Robert Perron, Lucie Charpentier, Céline Van Themsche, Ana Maria Eiján, Gervais Bérubé, Carlos Reyes-Moreno Biochemical Pharmacology.2020; 176: 113778. CrossRef
Loss of TRIM29 suppresses cancer stem cell-like characteristics of PDACs via accelerating ISG15 degradation Jia Sun, Jing Yan, Huai-Yu Qiao, Fu-Ying Zhao, Chao Li, Jing-Yi Jiang, Bao-Qin Liu, Xiao-Na Meng, Hua-Qin Wang Oncogene.2020; 39(3): 546. CrossRef
The Tripartite Nexus: Autophagy, Cancer, and Tripartite Motif-Containing Protein Family Members Michael A. Mandell, Bhaskar Saha, Todd A. Thompson Frontiers in Pharmacology.2020;[Epub] CrossRef
Macrophage Membrane-Coated Nanoparticles Alleviate Hepatic Ischemia-Reperfusion Injury Caused by Orthotopic Liver Transplantation by Neutralizing Endotoxin
Zhibing Ou, Hua Zhong, Liang Zhang, Minghua Deng, Wenfeng Zhang, Jingyuan Wang, Huaguo Feng, Jianping Gong, Chunmu Miao, Zhujun Yi International Journal of Nanomedicine.2020; Volume 15: 4125. CrossRef
TRIM59 inhibits PPM1A through ubiquitination and activates TGF-β/Smad signaling to promote the invasion of ectopic endometrial stromal cells in endometriosis Fengyu Wang, Haili Wang, Lei Sun, Chengling Niu, Jie Xu American Journal of Physiology-Cell Physiology.2020; 319(2): C392. CrossRef
Long non‑coding RNA TP73‑AS1 accelerates the progression and cisplatin resistance of non‑small cell lung cancer by upregulating the expression of TRIM29 via competitively targeting microRNA‑34a‑5p Shunxiang Luo, Ming Shen, Hui Chen, Weiwei Li, Cong Chen Molecular Medicine Reports.2020;[Epub] CrossRef
Robust Sample-Specific Stability Selection with Effective Error Control Heewon Park, Makoto Yamada, Seiya Imoto, Satoru Miyano Journal of Computational Biology.2019; 26(3): 202. CrossRef
Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway Hao Shen, Jiawei Zhang, Yaodong Zhang, Qinchao Feng, Hongwei Wang, Gaochao Li, Wangjie Jiang, Xiangcheng Li Gene.2019; 698: 50. CrossRef
MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29 Huimin Du, Qing Xu, Sheng Xiao, Zhenru Wu, Jianping Gong, Changan Liu, Guosheng Ren, Hao Wu Life Sciences.2019; 224: 1. CrossRef
ATDC contributes to sustaining the growth and invasion of glioma cells through regulating Wnt/β-catenin signaling Yidong Cao, Luoning Shi, Maode Wang, Juanru Hou, Yanqiang Wei, Changwang Du Chemico-Biological Interactions.2019; 305: 148. CrossRef
MicroRNA-621 inhibits cell proliferation and metastasis in bladder cancer by suppressing Wnt/β-catenin signaling Haili Tian, Xiaoqiang Wang, Jianfeng Lu, Weiping Tian, Peijie Chen Chemico-Biological Interactions.2019; 308: 244. CrossRef
Regulator of G protein signaling 20 promotes proliferation and migration in bladder cancer via NF-κB signaling Gang Li, Meng Wang, Liangliang Ren, Hanzong Li, Qinghua Liu, Ying Ouyang, Lixin He, Fengyan Li Biomedicine & Pharmacotherapy.2019; 117: 109112. CrossRef
ATDC promotes the growth and invasion of hepatocellular carcinoma cells by modulating GSK‐3β/Wnt/β‐catenin signalling Weizhi Li, Hui Xue, Yingchao Li, Peijie Li, Fuquan Ma, Mengying Liu, Shuzhen Kong Clinical and Experimental Pharmacology and Physiology.2019; 46(9): 845. CrossRef
MicroRNA-449a functions as a tumor suppressor in pancreatic cancer by the epigenetic regulation of ATDC expression Feng Li, Jing Liang, Lu Bai Biomedicine & Pharmacotherapy.2018; 103: 782. CrossRef
iTRAQ-based quantitative proteomic analysis of differentially expressed proteins in chemoresistant nasopharyngeal carcinoma Kun Wang, Zhen Chen, Lu Long, Ya Tao, Qiong Wu, Manlin Xiang, Yunlai Liang, Xulin Xie, Yuan Jiang, Zhiqiang Xiao, Yahui Yan, Shiyang Qiu, Bin Yi Cancer Biology & Therapy.2018; 19(9): 809. CrossRef
TRIM29 as a prognostic predictor for multiple human malignant neoplasms: a systematic review and meta-analysis Chao Liang, Huiyu Dong, Chenkui Miao, Jundong Zhu, Jie Wang, Pu Li, Jie Li, Zengjun Wang Oncotarget.2018; 9(15): 12323. CrossRef
Overexpression of sigma‑1 receptor in MCF‑7 cells enhances proliferation via the classic protein kinase C subtype signaling pathway Yuqi Wu, Xueyan Bai, Xiaoyang Li, Chang Zhu, Zachary Wu Oncology Letters.2018;[Epub] CrossRef
TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway Ye Sun, Bing Ji, Yifei Feng, Yue Zhang, Dongjian Ji, Chunyan Zhu, Sen Wang, Chuan Zhang, Dongsheng Zhang, Yueming Sun Oncology Reports.2017; 38(1): 43. CrossRef
TRIM29 promotes progression of thyroid carcinoma via activating P13K/AKT signaling pathway Jinkai Xu, Zongyu Li, Qinghua Su, Jun Zhao, Jiancang Ma Oncology Reports.2017; 37(3): 1555. CrossRef
Intravesicular administration of sodium hyaluronate ameliorates the inflammation and cell proliferation of cystitis cystica et glandularis involving interleukin-6/JAK2/Stat3 signaling pathway Yongliang Ni, Shaohua Zhao, Xiaoxuan Yin, Haixin Wang, Qianqian Guang, Guangxia Hu, Yi Yang, Shoubin Jiao, Benkang Shi Scientific Reports.2017;[Epub] CrossRef
High expression of TRIM29 (ATDC) contributes to poor prognosis and tumor metastasis by inducing epithelial-mesenchymal transition in osteosarcoma Si-Xiang Zeng, Qing-Chun Cai, Chi-Hua Guo, Li-Qiang Zhi, Xing Dai, Dang-Feng Zhang, Wei Ma Oncology Reports.2017; 38(3): 1645. CrossRef
MicroRNA-186 regulates the invasion and metastasis of bladder cancer via vascular endothelial growth factor C Xuefeng He, Jigen Ping, Duangai Wen Experimental and Therapeutic Medicine.2017; 14(4): 3253. CrossRef